A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: A case report including the biologic and phenotypic characteristics of the cell line

Cancer

Volumn 79, Issue 10, 1997, Pages 2036-2044

  Hiraiwa, Hisayuki ^a   Hamazaki, Minoru ^a   Takata, Ayako ^b   Kikuchi, Haruto ^b   Hata, Jun Ichi ^b  

^a SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

cell line; change of phenotype; clonal selection or evolution; mass screening; N myc gene; neuroblastoma; pediatric oncology

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER SCREENING; CASE REPORT; HISTOPATHOLOGY; HUMAN; JAPAN; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR BIOPSY;

BIOLOGY; CATECHOLAMINES; CELL DIVISION; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CULTURE TECHNIQUES; CYTOSKELETON; DIPLOIDY; DNA, NEOPLASM; FIBRONECTINS; GENE AMPLIFICATION; GENES, MYC; HUMANS; JAPAN; KARYOTYPING; MALE; MASS SCREENING; NEURITES; NEUROBLASTOMA; NEURONS; PHENOTYPE; POLYPLOIDY; THORACIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELLS; VIMENTIN;

EID: 0030906897     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<2036::AID-CNCR27>3.0.CO;2-U     Document Type: Article

References (30)

1. Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, et al. Mass screening for neuroblastoma in infants in Japan. Lancet 1984;2:271-3.
2. Bessho F, Hashizume K, Nakajo T, Kamoshita S. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 1991;119:237-41.
3. Hachitanda Y, Ishimoto K, Hata J, Shimada H. One hundred neuroblastomas detected through a mass screening system in Japan. Cancer 1994;74:3223-6.
4. Grosfeld JL, Rescorla FJ, West KW, Goldman J. Neuroblastoma in the first year of life: clinical and biological factors influencing outcome. Semin Pediatr Surg 1993;2:37-46.
5. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
7. Yunis JJ. New chromosome techniques in the study of human neoplasia. Hum Pathol 1981;12:540-9.
8. Bagwell CB. Theory and application of DNA histogram analysis [Ph.D. Thesis]. Miami (FL): The University of Miami, 1979.
9. Schwab M, Alitalo K, Klempnauer K, Varmus HE, Bishop JM, Gilbert F, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983; 305:245-8.
10. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 1970;30:2110-8.
11. Shimada H, Stram DO, Chatten J, Joshi W, Hachitanda Y, Brodeur GM, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995;87:1470-6.
12. Brodeur GM, Fong C. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989;41:153-74.
13. Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, et al. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer 1993; 72:3346-54.
14. Yoshihara T, Esumi N, Humphries MJ, Imashuku S. Unique expression of integrin fibronectin receptors in human neuroblastoma cell lines. Int J Cancer 1992;51:620-6.
15. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
16. Brodeur GM, Hayes FA, Green AA, Casper JT, Wasson J, Wallach S, et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 1987;47:4248-53.
17. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
18. Muraji T, Okamoto E, Fujimoto J, Suita S, Nakagawara A. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma: complementary prognostic indicators. Cancer 1993;72:2763-8.
19. Bigner SH, Freidman HS, Vogelstein B, Oakes WJ, Bigner DD. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 1990;50:2347-50.
20. Akiyama K, Kanda N, Yamada M, Tadokoro K, Matsunaga T, Nishi Y. Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas. Nucleic Acids Res 1994;22:187-93.
21. Cheng NC, Roy NV, Chan A, Beitsma M, Westerveld A, Speleman F, et al. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 1995;10:291-7.
22. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosom Cancer 1994;10:30-9.
23. Corvi R, Savelyeva E, Schwab M. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 1995;55:3471-4.
24. Misra DN, Dickman PS, Yunis EJ. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. Diagn Mol Pathol 1995;4:128-35.
25. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization: diagnostic utility for neuroblastoma. Am J Pathol 1993;142:1339-46.
26. Taylor CPF, McGuckin AG, Bown NP, Reid MM, Malcolm AJ, Pearson ADJ, et al. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. Br J Cancer 1994;69:445-51.
27. Hoehner JC, Hedborg F, Wiklund HJ, Olsen L, Pahlman S. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 1995;62:19-24.
28. Iwata M, Koshinaga T, Okabe I, Kurosu Y, Esumi M. Biological characteristics of neuroblastoma with spontaneous tumor reduction: a case report. J Pediatr Surg 1995;30:722-3.
29. D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1971;1:1046-9.
30. Committee on neuroblastoma, Japanese Society of Pediatric Oncology. Summary of mass screening system [in Japanese, authors' translation] Jpn J Pediatr Oncol 1996;33:278-83.